Shanghai Zhongshan Hospital: Stomach Neoplasms trials

The registry lists 27 Stomach Neoplasms studies with Shanghai Zhongshan Hospital as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 8Phase 3 2No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric CancerNot yet recruitingNCT07333573Phase 1/2
• Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric CancerNot yet recruitingNCT07096752
• A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric CancerNot yet recruitingNCT06706895Phase 2
• IMmune Proteomics to Predict NeoAdjuvant Chemotherapy and ImmunoTherapy Response in Gastric CancerRecruitingNCT06662110
• Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric CancerRecruitingNCT06468280Phase 2
• Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical ApplicationNot yet recruitingNCT06335576
• A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric CancerNot yet recruitingNCT05396326Phase 1
• Neoadjuvant TACiE in Locally Advanced Gastric CancerNot yet recruitingNCT05346874Phase 2
• Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric CancerRecruitingNCT04710758Not applicable
• Methylation Analysis of Circulating Tumor DNA in Gastric CancerNot yet recruitingNCT04511559
• Establishment of Molecular Classification Models for Early Diagnosis of Digestive System CancersCompletedNCT05431621
• Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric CancerStatus unknownNCT05311189Phase 2
• AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-GastricStatus unknownNCT05224596
• The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular ProfilingStatus unknownNCT04501887
• Potential Clinical Utilities of Circulating Tumor DNA in Gastric CancerStatus unknownNCT04000425
• Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric CancerStatus unknownNCT03977220Phase 1
• Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. ChemoradiotherapyStatus unknownNCT03680261Phase 3
• Incidence of Pancreatic Fistula After Radical GastrectomyStatus unknownNCT03391687
• Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric CancerStatus unknownNCT03229096Phase 2
• Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric CancerCompletedNCT03007550Not applicable
• To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.Status unknownNCT03001726
• Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin BlocksStatus unknownNCT02852096Not applicable
• The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using ImmunohistochemistryStatus unknownNCT02843412
• A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric CancerStatus unknownNCT02409199Phase 2/3
• the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric CancerStatus unknownNCT02385578Not applicable
• Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node MetastasisCompletedNCT02071043Phase 2
• Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric CancerCompletedNCT01943253Not applicable